Tell us about your product, market, and timeline — our specialists will design a testing programme that fits.
Our scientific team will help you identify the right tests, methods, and accreditations for your product or sample.
Herbal, Ayurvedic, Unani, Siddha & AYUSH Testing
Auriga Research is India's first herbal testing lab licensed by the Directorate of ISM&H. We are NABL-accredited and AYUSH-approved for testing herbal, Ayurvedic, Siddha, Unani, and Homeopathy products at Delhi HQ (AYUSH approval since 2004 plus the Unani licence) and Bahadurgarh (Alcatec, AYUSH-approved). Scope covers heavy metals, pesticide residues, microbial limits, aflatoxins, undeclared synthetic drugs and steroids, DNA-based identification and fingerprinting, residual solvents, stability per AYUSH GMP, and standardisation per Ayurvedic Pharmacopoeia of India (API).
Accreditations & Approvals




















Herbal and AYUSH manufacturers face tightening regulations on heavy metal limits, pesticide residues, and undeclared drug adulteration. The Ministry of AYUSH and CDSCO require accredited test data for product licensing. Without reliable testing, products risk rejection, recalls, and reputational damage.
Auriga Research provides NABL-accredited herbal testing with pharmacopoeial-grade methods for heavy metals, pesticides, microbiology, and steroid detection. Our stability testing programme for herbal drugs generates the shelf-life data required for AYUSH registration, ensuring your products meet every regulatory checkpoint.
End-to-end testing for herbal raw materials, botanical extracts, and finished AYUSH products — from identity to stability.
Lead, mercury, arsenic, and cadmium by ICP-MS per API, WHO, and USP limits. Bhasma preparations follow API-specific limits, distinct from standard herbal-extract limits.
Learn more →Multi-residue screening for 200+ pesticides in botanical raw materials and finished herbal products by GC-MS and LC-MS/MS.
Learn more →Total aerobic count, yeast and mould, E. coli, Salmonella, and Staphylococcus aureus per pharmacopoeial methods.
Learn more →Identity verification and HPTLC chromatographic fingerprinting per pharmacopoeial herbal monographs — the identity + fingerprint layer of the AYUSH licence dossier.
Learn more →Quantitative HPLC and HPTLC marker assay — withanolides, curcuminoids, andrographolide, piperine, gymnemic acid, boswellic acids, glycyrrhizin, bacosides, ginsenosides, and custom markers.
Learn more →Qualitative and semi-quantitative screening for alkaloid, flavonoid, tannin, saponin, glycoside, and other phytoconstituent classes per API and WHO methods.
Learn more →LC-MS/MS screening for undeclared synthetic adulterants — corticosteroids, NSAIDs, PDE5 inhibitors, and other commonly adulterated compounds in herbal and Ayurvedic formulations.
Learn more →DNA-barcoding and chromatographic fingerprinting to confirm botanical identity of herbal raw materials and rule out species substitution.
Aflatoxins B1, B2, G1, G2, and total aflatoxin by HPLC-FLD and LC-MS/MS. AYUSH herbal limits differ from food aflatoxin limits — quoted against the correct AYUSH / API monograph.
Learn more →Accelerated and real-time stability studies per AYUSH GMP Schedule T and Zone IV (30 °C / 75 % RH) conditions for shelf-life claims on AYUSH licence dossiers and export packs.
Learn more →HS-GC-FID and GC-MS residual solvent testing per ICH Q3C and USP 467 for herbal extracts and AYUSH preparations. Class 1, 2, and 3 panels.
Learn more →Identity, purity, and quality testing per the Unani Pharmacopoeia of India (UPI) and Siddha Pharmacopoeia of India (SPI). Delhi HQ holds the Unani licence and covers Siddha scope for state AYUSH licensing.
Adulteration of herbal and Ayurvedic products with undeclared synthetic drugs is a serious regulatory and safety concern. Auriga Research operates a dedicated LC-MS/MS screening programme to detect corticosteroids (dexamethasone, betamethasone, prednisolone), NSAIDs (diclofenac, piroxicam), PDE5 inhibitors (sildenafil, tadalafil), and other commonly adulterated synthetic compounds in herbal formulations.
This testing is essential for manufacturers facing regulatory audits, brands protecting consumer safety, and exporters meeting destination-country requirements. Our screening methods are validated against USP and WHO guidelines, and results are issued under NABL accreditation.
Need steroid or drug adulteration testing for your herbal product? Submit a sample for NABL-accredited LC-MS/MS analysis.
Herbal and AYUSH testing scope is held at two Auriga labs, each with distinct credentials covering different parts of the AYUSH framework.
Primary AYUSH Lab
India's first ISM&H-licensed herbal testing facility. Full AYUSH scope including Ayurvedic Pharmacopoeia (API), Unani Pharmacopoeia (UPI), Siddha Pharmacopoeia (SPI), Homeopathy, plus DNA-based identification, steroid screening, and bhasma API-specific limits.
View Delhi Lab →Secondary AYUSH Lab
Alcatec Research Laboratories, a fully owned subsidiary of Auriga Research. AYUSH-approved scope supports heavy metals, pesticide residues, microbial limits, and environmental-adjacent herbal raw material work.
View Bahadurgarh Lab →India's first herbal testing lab licensed by the Directorate of Indian System of Medicine and Homoeopathy (ISM&H). A verifiable, unique credential that no other commercial lab in the herbal segment holds.
AYUSH approval held at both Delhi HQ (since 2004, DTL-01 A&U) and Bahadurgarh (Alcatec). Unani licence held at Delhi HQ. Full API, UPI, SPI, and Homeopathy pharmacopoeial scope.
DNA barcoding and chromatographic fingerprinting to confirm botanical identity of raw materials and rule out species substitution — a capability most herbal labs do not offer.
LC-MS/MS screening for undeclared corticosteroids, NSAIDs, PDE5 inhibitors, and other synthetic adulterants in herbal and Ayurvedic formulations. Protects brand from regulatory and reputational risk.
Bhasma metal and mineral preparations tested against API-specific heavy metal limits — not standard herbal-extract limits. Most labs apply the wrong limit; we apply the correct one.
NABL-accredited (ISO/IEC 17025:2017) reports accepted by the Ministry of AYUSH, CDSCO, state AYUSH licensing authorities, and export regulatory bodies including EU and WHO pharmacopoeial reviewers.
Six buyer profiles that route herbal, Ayurvedic, Unani, Siddha, and Homeopathy testing to Auriga.
Four steps from quote to NABL-accredited report.
Share your product type (herbal extract, Ayurvedic / Unani / Siddha / Homeopathy formulation, bhasma, nutraceutical), the AYUSH framework, and target market. Your dedicated SPOC confirms the test panel, sample quantity, and the relevant pharmacopoeial reference before you dispatch.
Dispatch product samples in commercial packaging with a completed Test Request Form to the Delhi HQ (Arbro Analytical Division) or Bahadurgarh (Alcatec) lab. Each sample is bar coded and registered in YLIMS, Auriga's in-house Laboratory Information Management System, upon receipt.
Your sample is tested per the relevant pharmacopoeia (API, UPI, SPI, IP, USP) for the agreed panel — heavy metals (incl. bhasma API limits), pesticide residues, microbial limits, aflatoxins, DNA identity, steroid and adulterant screening, residual solvents, or stability. Every result passes through formal internal QA review and sign-off before the report is generated.
Your NABL-accredited herbal / AYUSH report is delivered digitally within the committed turnaround time. Reports are accepted by the Ministry of AYUSH, CDSCO, state AYUSH licensing authorities, and export regulatory bodies. Track sample status in real time through YLIMS.
Auriga Research holds NABL accreditation under ISO/IEC 17025:2017 for herbal and AYUSH product testing. Our scope covers heavy metals by ICP-MS, pesticide residues by GC-MS/LC-MS/MS, microbiological testing, aflatoxin analysis, and stability studies under ICH-aligned conditions.
Test reports are accepted by the Ministry of AYUSH for product licensing, CDSCO for drug registration, state AYUSH licensing authorities, and export regulatory bodies. Our methods align with Ayurvedic Pharmacopoeia of India (API), WHO guidelines for herbal medicines, and USP monographs for botanical products.
An Ayurvedic manufacturer required urgent steroid screening after a regulatory query flagged one of their formulations. Auriga Research completed LC-MS/MS screening for 30+ synthetic compounds within 5 working days, confirmed the product was free of undeclared drugs, and issued a NABL-accredited certificate of analysis. The report cleared the regulatory query and the product remained on the market without disruption.
NABL-accredited herbal and AYUSH testing at Delhi HQ (Unani licensed) and Bahadurgarh (Alcatec). Heavy metals, pesticides, steroids, DNA fingerprinting, bhasma API-specific limits, and full pharmacopoeial analysis.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Download Guide Request a Quote InsteadNo thanks, I'll keep browsing